25B-NBF

25B-NBF
25B-NBF.svg
Clinical data
ATC code
  • (HCl): none
Identifiers
CAS Number
ChemSpider
Chemical and physical data
3D model (JSmol)

25B-NBF (2C-B-NBF, NBF-2C-B) is a derivative of the phenethylamine hallucinogen 2C-B, which acts as a highly potent partial agonist for the human 5-HT2A receptor.[1]

Legality[edit]

Sweden[edit]

The Riksdag added 25B-NBF to Narcotic Drugs Punishments Act under swedish schedule I (“substances, plant materials and fungi which normally do not have medical use”) as of January 26, 2016, published by Medical Products Agency (MPA) in regulation HSLF-FS 2015:35 listed as 25B-NBF, and 2-(4-bromo-2,5-dimetoxifenyl)-N-(2-fluorobensyl)etanamin.[2]

United Kingdom[edit]

This substance is a Class A drug in the United Kingdom as a result of the N-benzylphenethylamine catch-all clause in the Misuse of Drugs Act 1971.[3]

Analogues and derivatives[edit]

References[edit]

  1. ^ Hansen, Martin (16 December 2010). “PhD Thesis”. bitnest.netfirms.com. University of Copenhagen.
  2. ^ “Data” (PDF). lakemedelsverket.se. 2015.
  3. ^ “The Misuse of Drugs Act 1971 (Ketamine etc.) (Amendment) Order 2014”. www.legislation.gov.uk.